| 0 | 💬 0 |
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-06-15 | #infection #virulence #clinical trial #antiviral #rsv |